nterminal domain antiandrogen antagonist nterminal domain ntd androgen receptor ar development treatment prostate compound developed successor previous drugs epi series ralaniten ralaniten acetate shows higher antiandrogenic potency ralaniten vitro halfmaximal inhibitory concentration nm vs nm respectively well greater stability human planned enter phase clinical trials drug article relating genitourinary system stub help wikipedia expanding